Clinical trial
Morphine-Sparing Efficacy Of Parecoxib In Pain Treatment After Radical…
NCT00346268 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00346268 |
|---|---|
| Title | Morphine-Sparing Efficacy Of Parecoxib In Pain Treatment After Radical Prostatectomy |
| Official title | Randomized, Double-Blind Study Of The Morphine-Sparing Efficacy And Safety Of Parecoxib Sodium 40 Mg IV Followed By 20 Mg IV Every 12 Hours In The Treatment Of Pain Following Radical Prostatectomy |
| Acronym | PROSTATECTOMY |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pain, Postoperative |
| Intervention type | Drug |
| Interventions | Morphine, Parecoxib, Placebo |
| Enrollment | 105 |
| Start date | Dec 1, 2006 |
| Primary completion | Sep 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Jun 29, 2006 |
| Last update posted | Oct 28, 2011 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: